Research graph
References from Comparative evaluation of the sarcopenia index and 5 related creatinine–cystatin C biomarkers in relation to all-cause mortality in older adults. Local targets link to admitted publications; unresolved targets remain external evidence.
Sarcopenia: revised European consensus on definition and diagnosis.
10.1093/ageing/afy169 · 2019 · External reference
Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment.
10.1016/j.jamda.2019.12.012 · 2020 · External reference
Associations of muscle mass and strength with all-cause mortality among US older adults.
10.1249/mss.0000000000001448 · 2018 · External reference
Epidemiology of sarcopenia: prevalence, risk factors, and consequences.
10.1016/j.metabol.2023.155533 · 2023 · External reference
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
10.1136/bmj-2021-068788 · 2022 · External reference
Biomarkers for physical frailty and sarcopenia: state of the science and future developments.
10.1002/jcsm.12051 · 2015 · External reference
Looking for sarcopenia biomarkers.
10.1016/j.amjmed.2017.01.018 · 2017 · External reference
Cystatin C versus creatinine in determining risk based on kidney function.
10.1056/nejmoa1214234 · 2013 · External reference
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.
10.1111/j.1523-1755.2004.00517.x · 2004 · External reference
Factors other than glomerular filtration rate affect serum cystatin C levels.
10.1038/ki.2008.638 · 2009 · External reference
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.
10.2215/cjn.02870707 · 2008 · External reference
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.
10.1016/j.kint.2023.10.018 · 2024 · External reference
A novel creatinine muscle index based on creatinine filtration: associations with frailty and mortality.
10.1681/asn.0000000000000037 · 2023 · External reference
Sex differences in cardiac risk and kidney function: serum creatinine versus cystatin C.
10.1186/s12916-025-04588-9 · 2025 · External reference
Estimation of muscle mass using creatinine/cystatin C ratio in Japanese community-dwelling older people.
10.1016/j.jamda.2021.07.029 · 2022 · External reference
A new equation to estimate muscle mass from creatinine and cystatin C.
10.1371/journal.pone.0148495 · 2016 · External reference
Predicted skeletal muscle index as a scalable marker for sarcopenia risk and mortality in older Chinese adults.
10.3389/fmed.2025.1640410 · 2025 · External reference
Association of serum creatinine-cystatin C ratio with hospital-associated complications and post-discharge mortality.
10.1111/ggi.70206 · 2025 · External reference
Association of serum creatinine-cystatin C ratio with all-cause, cardiovascular and cancer mortality in US adults: a nationwide cohort study.
10.1186/s12877-024-05546-5 · 2024 · External reference
Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease.
10.1038/s41598-021-96447-9 · 2021 · External reference
Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and mortality in the general population.
10.1093/clinchem/hvaf063 · 2025 · External reference
Association of intraindividual difference in estimated glomerular filtration rate by creatinine vs cystatin C and end-stage kidney disease and mortality.
10.1001/jamanetworkopen.2021.48940 · 2022 · External reference
Discordances between creatinine- and cystatin C-based estimated GFR and adverse clinical outcomes in routine clinical practice.
10.1053/j.ajkd.2023.04.002 · 2023 · External reference
Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ije/dys203 · 2014 · External reference
Estimating glomerular filtration rate from serum creatinine and cystatin C.
10.1056/nejmoa1114248 · 2012 · External reference
New creatinine- and cystatin C-based equations to estimate GFR without race.
10.1056/nejmoa2102953 · 2021 · External reference
Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults.
2011 · External reference
Physical performance and risk of hip fracture in community-dwelling elderly people in China: a 4-year longitudinal cohort study.
10.1016/j.maturitas.2021.01.003 · 2021 · External reference
Proportional hazards tests and diagnostics based on weighted residuals.
10.1093/biomet/81.3.515 · 1994 · External reference
A more accurate method to estimate muscle mass: a new estimation equation.
10.1002/jcsm.13254 · 2023 · External reference
Creatinine, cystatin C, muscle mass, and mortality: findings from a primary and replication population-based cohort.
10.1002/jcsm.13511 · 2024 · External reference
Different eGFR markers and prediction of cardiovascular risk.
10.1111/joim.70050 · 2026 · External reference
Multicollinearity and misleading statistical results.
10.4097/kja.19087 · 2019 · External reference
Equivalence of the mediation, confounding and suppression effect.
10.1023/a:1026595011371 · 2000 · External reference
Longitudinal changes in plasma Cystatin C and all-cause mortality risk among the middle-aged and elderly Chinese population.
10.1016/j.clinbiochem.2024.110858 · 2025 · External reference
